Cetera Investment Advisers’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Sell
29,557
-1,872
-6% -$192K ﹤0.01% 2092
2026
Q1
$3.43M Buy
31,429
+73
+0.2% +$6.96K ﹤0.01% 1791
2025
Q4
$2.54M Buy
31,356
+2,699
+9% +$232K ﹤0.01% 2009
2025
Q3
$2.51M Buy
28,657
+16,338
+133% +$1.46M ﹤0.01% 1979
2025
Q2
$1.02M Buy
12,319
+3,797
+45% +$317K ﹤0.01% 2354
2025
Q1
$715K Buy
8,522
+5,769
+210% +$537K ﹤0.01% 2543
2024
Q4
$254K Buy
2,753
+284
+12% +$27.3K ﹤0.01% 3242
2024
Q3
$229K Buy
+2,469
New +$214K ﹤0.01% 3287
2023
Q1
Sell
-4,372
Closed -$201K 2211
2022
Q4
$201K Buy
+4,372
New +$205K ﹤0.01% 1902

Other funds holding LMAT

Cetera Investment Advisers's LMAT Position: Q2 2026 in Review

Cetera Investment Advisers reduced its LeMaitre Vascular (LMAT) stake by 6% in Q2 2026, selling an estimated $192K and leaving 29,557 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

Cetera Investment Advisers first reported a position in LMAT in Q4 2022 and has held it in 9 quarters since. The position peaked at $3.43M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Cetera Investment Advisers held 29,557 shares of LeMaitre Vascular worth $2.84M as of Q2 2026.
  • Cetera Investment Advisers sold 1,872 LeMaitre Vascular shares in Q2 2026, an estimated $192K.
  • LeMaitre Vascular made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2092 holding.
  • Cetera Investment Advisers first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 9 quarters since.
  • Cetera Investment Advisers's LeMaitre Vascular position peaked at $3.43M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.